Artificial intelligence tools are increasingly being developed to predict cancer biology directly from microscope images, ...

University of Warwick research warns that popular deep learning systems trained for cancer pathology may be relying on hidden ...

Artificial intelligence is transforming medicine, but what does that mean for breast cancer screening? Researchers at UMass Chan Medical School are exploring how an AI-based tool might help identify ...

When the performance of AI models was assessed within stratified patient subgroups, such as only high-grade breast cancers or ...

Academia Sinica and National Taiwan University (NTU) Hospital have jointly developed PanMETAI, an AI metabolomics platform to detect the early stages of pancreatic cancer. The tabular AI model detects ...

An innovative biotech startup founded by researchers at Washington University School of Medicine in St. Louis has been acquired by Lunit, a leading company in developing AI-based technologies for ...

Pancreatic cancer has long been regarded by the medical community as the most challenging cancer to diagnose due to its unspecific early symptoms and the lack of effective screening tools.

Optellum, a 2016 spinout from the University of Oxford, has been tapped by the U.K.’s National Health Service (NHS) to use its artificial-intelligence-powered lung cancer diagnostic as part of an ...